NASDAQ:GEHC • US36266G1076
Past quarterly earnings results for GE HEALTHCARE TECHNOLOGY (GEHC), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 1.44 | 1.43 | 0.96% | -0.69% | 5.698B | 5.723B | -0.44% | 7.13% |
| Q3 2025 | 1.07 | 1.07 | -0.16% | -6.14% | 5.143B | 5.182B | -0.75% | 5.76% |
| Q2 2025 | 1.06 | 0.94 | 13.24% | 6.00% | 5.007B | 5.062B | -1.09% | 3.47% |
| Q1 2025 | 1.01 | 0.93 | 8.42% | 12.22% | 4.777B | 4.757B | 0.42% | 2.73% |
| Q4 2024 | 1.45 | 1.29 | 12.49% | 22.88% | 5.319B | 5.437B | -2.17% | 2.17% |
| Q3 2024 | 1.14 | 1.07 | 6.17% | 15.15% | 4.863B | 4.966B | -2.07% | 0.85% |
| Q2 2024 | 1.00 | 1.00 | 0.18% | 8.70% | 4.839B | 4.97B | -2.64% | 0.46% |
| Q1 2024 | 0.90 | 0.92 | -2.68% | 5.88% | 4.65B | 4.897B | -5.04% | -1.21% |
| Q4 2023 | 1.18 | 1.09 | 8.08% | -9.92% | 5.206B | 5.193B | 0.25% | 5.43% |
| Q3 2023 | 0.99 | 0.91 | 8.23% | - | 4.822B | 4.901B | -1.61% | 5.38% |
| Q2 2023 | 0.92 | 0.89 | 3.67% | - | 4.817B | 4.89B | -1.49% | -45.43% |
| Q1 2023 | 0.85 | 0.81 | 5.15% | - | 4.707B | 4.727B | -0.42% | - |
| Q4 2022 | 1.31 | - | - | 4.938B | - | 7.61% | ||
| Q3 2022 | - | - | 4.576B | - | 6.32% | |||
| Q2 2022 | - | - | 8.827B | - | 1.55% | |||
| Q4 2021 | - | - | 4.589B | - | - | |||
| Q3 2021 | - | - | 4.304B | - | - | |||
| Q2 2021 | - | - | 8.692B | - | - |
Notes
GE HEALTHCARE TECHNOLOGY (GEHC) last reported earnings on 2/4/2026.
GE HEALTHCARE TECHNOLOGY (GEHC) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, GE HEALTHCARE TECHNOLOGY (GEHC) has beaten EPS estimates in 3 out of 4 releases.